Shawnte Mitchell - Feb 18, 2025 Form 3 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Signature
/s/ Shane Kovacs, Attorney-in-Fact
Stock symbol
OLMA
Transactions as of
Feb 18, 2025
Transactions value $
$0
Form type
3
Date filed
2/28/2025, 04:15 PM
Previous filing
Mar 9, 2022
Next filing
Mar 3, 2025

No securities are beneficially owned.